Specifically, non-fatal myocardial infarction occurred in three (3%) vs. seven (7%), stroke in two (2%) vs. five (5%), and cardiovascular death in two (2%) vs. four (4%) in the PCSK9 and control groups, respectively. This evidence concerns the gene PCSK9 and Stroke.